MarketPeel
Insider Trading Intelligence
MV

Manuela Valente

SOPH
CHIEF PEOPLE OFFICER · SOPHIA GENETICS SA · CIK 0002009280
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$69.7K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
210,450
AVG SELL PX
$4.91
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 16 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Manuela Valente, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%-1.10%+2.34%-3.44%-4.12%
14d5+0.00%+4.11%+4.05%+0.05%+0.35%
30d5+20.00%+3.51%+9.77%-3.21%-1.96%
60d5+40.00%-0.55%+10.74%-11.30%-10.37%
90d5(1 pending)+0.00%+7.20%+12.72%-5.52%-4.37%
180d5(5 pending)
1y5(5 pending)
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 210,450 shares · as of Jul 6, 2026
056,062112,124168,186224,248SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
2026
FLOW · 4 buys / 7 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,241$5.05$21.4K210,450Jul 6, 2026Jul 7, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
380$4.60$1.7K214,691May 19, 2026May 20, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
380$5.20$2.0K215,071Apr 20, 2026Apr 21, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,824$4.85$18.5K215,451Apr 8, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,376$4.87$11.6K219,275Apr 7, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,597$4.85$12.6K221,651Apr 6, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
71,86971,869Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
104,790104,790Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
104,790104,790Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
71,869224,248Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
380$4.79$1.8K152,379Mar 19, 2026Mar 20, 2026View →
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002009280
ROLE
Chief People Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002009280DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback